Clinical Trials Directory

Trials / Completed

CompletedNCT01322893

Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Lund University Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Women with metastatic breast cancer, receiving first line treatment of any kind (chemotherapy, endocrine treatment or treatment with antibodies) will be included in this trial. In connection to treatment, blood samples for determination and enumeration of circulating tumour cells will be collected at different time points. Serum and plasma will be collected and stored for future analysis of RNA and DNA.

Conditions

Timeline

Start date
2011-03-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2011-03-25
Last updated
2020-05-22

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01322893. Inclusion in this directory is not an endorsement.

Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer (NCT01322893) · Clinical Trials Directory